Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India

Chemical Research in Toxicology

Volumn 14, Issue 4, 2001, Pages 371-378

  Mandal, B K ^a   Ogra, Y ^a   Suzuki, K T ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; ARSENOBETAINE; ARSENOCHOLINE; CACODYLIC ACID; DIMETHYLARSINOUS ACID; DRINKING WATER; GLUTATHIONE; METHANEARSONIC ACID; METHYLARSONOUS ACID; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANION EXCHANGE; ARSENIC POISONING; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DETOXIFICATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METHYLATION; TECHNIQUE; URINALYSIS; VALIDATION PROCESS; WATER CONTAMINATION;

ARSENIC; CACODYLIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL POLLUTANTS; HUMANS; INDIA; MASS SPECTROMETRY; ORGANOMETALLIC COMPOUNDS; SENSITIVITY AND SPECIFICITY;

EID: 0035056158     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000246h     Document Type: Article

References (61)

1. Arsenic speciation in the environment
2. Methylation study of a population environmentally exposed to arsenic in drinking water
3. Cancer risks from arsenic in drinking water
4. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water
5. Arsenic ingestion and internal cancers: A review
6. Dose - Response relation between arsenic concentration in well water and mortality from cancers and vascular diseases
7. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water
8. Arsenic dose in patients with cutaneous carcinomata and hepatic haemangio-endothelioma after environmental and occupational exposure
9. Species differences in the metabolism of arsenic compounds
10. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity
11. 74As) in humans following oral ingestion
12. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man
13. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic
14. Enzymatic methylation of arsenic compounds. I. Assay, partial purification and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver
15. The reaction of methylarsenicals with thiols: Some biological implications
16. The metabolism of methylarsine oxide and sulfide
17. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic
18. Toxicity and metabolism of inorganic and methylated arsenicals
19. Cellular response to oxidative damage in lung induced by administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice
20. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals
21. Possible involvement of methylarsenics produced metabolically from inorganic arsenics in arsenic-induced carcinogenesis: The contribution of preferential formation of dimethylarsenic radicals
22. Liberation and analysis of protein-bound arsenicals
23. Binding of arsenicals to proteins in an in vitro methylation system
24. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols
25. Reduction and binding of arsenate and dimethylarsenate by glutathione: A multinuclear magnetic resonance study
26. Reaction of arsenic(III) and arsenic(V) species with glutathione
27. Study of inorganic arsenic methylation by rat in vitro: Relevance for the interpretation of observations in man
28. Mono and dimethylation of arsenic in rat liver cytosol in vitro
29. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase
30. III) is more toxic than arsenite in Chang human hepatocytes
31. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic
32. Arsenic species that causes release of iron from ferritin and generation of activated oxygen
33. Simultaneous speciation of arsenic and selenium compounds by ion chromatography with inductively coupled plasma mass spectrometry as elemental specific detector
34. Toxicological profile for arsenic, update
35. Risk and revisionism in arsenic cancer risk assessment
36. Speciation of arsenic compounds by using HPLC with hydride generation atomic absorption spectrometry and inductively coupled plasma mass spectrometry detection
37. Determination of arsenic compounds in human urine by HPLC-ICPMS
38. High performance liquid chromatography inductively coupled plasma mass spectrometry for speciation of arsenic compounds in urine
39. Speciation of arsenic and selenium compounds by HPLC hyphenated to specific detectors: A review of the main separation techniques
40. 74As-labelled arsenate and arsenite for use in biological experiments
41. Arsenic in ground water in seven districts of West Bengal, India: The biggest calamity in the world
42. Groundwater arsenic contamination in Bangladesh and West Bengal, India
43. Arsenic in ground water in six districts of West Bengal, India: The biggest arsenic calamity in the world, Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people
44. III), excreted in human urine
45. III) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes
46. Bilary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats
47. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
48. The enigma of arsenic carcinogenesis: Role of metabolism
49. A chemical hypothesis for arsenic methylation in mammals
50. Iron-induced carcinogenesis: The role of redox regulation
51. Comparative in vitro methylation of trivalent and pentavalent arsenicals
52. Speciation of key arsenic metabolic intermediates in human urine
53. Biological mechanisms and toxicological consequences of the methylation of arsenic
54. DMPS-arsenic challenge test. I. Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate
55. DMSA and DMPS-water soluble antidotes for heavy metal poisoning
56. Chronic arsenic poisoning in humans: The case of Mexico
57. Urinary excretion of arsenic species in a human population chronically exposed to arsenic via drinking water: A pilot study
58. V reductase